title: Intracardiac devices for stroke prevention.
abstract: Stroke is a significant cause of serious disability and death worldwide. A substantial proportion of strokes are related to an underlying cardiac embolic source, most commonly in association with atrial arrhythmias (fibrillation/flutter). Atrial fibrillation is considered a major risk factor for stroke. Although long-term prophylactic oral anticoagulation has been shown to be very effective in reducing stroke in patients with atrial fibrillation, it has a number of major limitations and is not feasible in all patients. In such cases, the use of percutaneously (transvenous) implanted left atrial appendage occlusive devices or surgical appendage obliteration is being explored. Similarly, the presence of a patent foramen ovale, especially in the presence of an atrial septal aneurysm, is now recognized as an important potential mediator of paradoxical cardiogenic embolism. Percutaneous patent foramen ovale closure is becoming increasingly established as a safe and effective means of preventing recurrent strokes in the presence of a patent foramen ovale. In this account, the authors discuss the intracardiac devices and techniques available and the relative merits of their use for stroke prevention.
authors.affiliation: Swiss Cardiovascular Center, Bern, Switzerland.
authors.forename: Thuraia
authors.initials: T
authors.lastname: Nageh
authors.forename: Bernhard
authors.initials: B
authors.lastname: Meier
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D020517:Atrial Appendage / Q000473:pathology / Q000601:surgery; D001281:Atrial Fibrillation / Q000150:complications; D019320:Embolism, Paradoxical / Q000150:complications; D006344:Heart Septal Defects, Atrial / Q000150:complications; D006353:Heart-Assist Devices; D006801:Humans; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants